White House secures deal on weight loss drugs
The White House has secured another deal with major pharmaceutical companies, this time to offer popular weight loss drugs for less in some cases.
On Thursday, the administration announced from the Oval Office that, starting in 2026, popular weight loss drugs Zepbound and Wegovy will be covered for some patients under Medicare and Medicaid. The drugs’ manufacturers, Eli Lilly and Novo Nordisk, have also agreed to sell Zepbound and Wegovy for reduced prices on the direct-to-consumer government website TrumpRx. TrumpRx is a kind of online marketplace where Americans can purchase prescription drugs at a reduced cost from the standard list price, if they don’t have or forgo using insurance.
The White House has said Ozempic and Wegovy will “fall from $1,000 and $1,350 per month, respectively, to $350” when purchased through TrumpRx, and to an average of $346 for Zepbound and Orforglipron, if approved.
“It’s a triumph for American patients that will save lives and improve the health of millions and millions of Americans,” said President Donald Trump.
The drug manufacturers have also agreed to guarantee most-favored-nation pricing on all new medicines that they bring to market, meaning the lowest price among the U.S. and its economic peer countries, in alignment with an earlier executive order from the president.
The drugs are known as GLP-1s. Originally prescribed for diabetes, doctors have begun prescribing them for weight loss, but they often aren’t covered by insurance when they are prescribed for that reason.
Eli Lilly and Novo Nordisk are the most recent pharmaceutical companies to offer medications on TrumpRx and at most-favored-nation pricing as part of an effort by the administration to reduce the cost of prescription drugs in the U.S.
Health and Human Services Secretary Robert F. Kennedy Jr. said Thursday’s deal was the biggest of the pharmaceutical deals the administration has announced so far, since the drugs have become so popular.
“This is the biggest drug in our country, and that’s why this is the most important of all the [most favored nation] announcements we’ve made,” Kennedy said. “This is going to have the biggest impact on the American people.”
Latest News Stories
WATCH: Trick or treat: IL legislators pass tax increase, decoupling bill early Friday
Noem refuses Pritzker enforcement pause request, IL passes sanctuary enhancement
WATCH: Energy bill opponents say increases IL electric bills by $8 billion passes
WA Dems blame GOP for government shutdown; 1 million in state could lose SNAP benefits
Officials react to allegations of civilians impersonating ICE
Illinois quick hits: IL taxpayers have highest pension debt obligations in U.S.
WATCH: Bonta visits food bank amid lawsuit over CalFresh
IL taxpayers to pay $20M for food banks as SNAP funding lapses start Saturday
Poll: 7 in 10 of Americans are against mail-order abortion without a doctor visit
Trump’s plan to re-start nuclear weapons testing faces criticism
Illinois quick hits: Corrections director appointment approved; Clean Slate Act passes
Tyler Robinson’s in-person hearing delayed to January